Cryo-EM structure of an amyloid fibril from systemic amyloidosis

Systemic AA amyloidosis is a worldwide occurring disease of humans and animals that arises from the misfolding of serum amyloid A protein. To provide insights into the molecular basis of this disease we used electron cryo-microscopy and determined the structure of an ex vivo amyloid fibril purified from AA amyloidotic mice at 3.0 Å resolution. The fibril consists of C-terminally truncated serum amyloid A protein arranged into a compactly folded all-β conformation. The structure identifies the protein N-terminus as central for the assembly of this fibril and provides a mechanism for its prion-like replication. Our data further explain how amino acid substitutions within the tightly packed fibril core can lead to amyloid resistance in vivo.

[1]  R. Riek,et al.  Structure of alpha-synuclein fibrils , 2018 .

[2]  R. Riek,et al.  Cryo-EM structure of alpha-synuclein fibrils , 2018, bioRxiv.

[3]  G. Schröder,et al.  Fibril structure of amyloid-β(1–42) by cryo–electron microscopy , 2017, Science.

[4]  A. Schierhorn,et al.  Influence of C-terminal truncation of murine Serum amyloid A on fibril structure , 2017, Scientific Reports.

[5]  A. Murzin,et al.  Cryo-EM structures of Tau filaments from Alzheimer’s disease brain , 2017, Nature.

[6]  C. Dobson,et al.  Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. , 2017, Annual review of biochemistry.

[7]  P. Walther,et al.  Cellular mechanism of fibril formation from serum amyloid A1 protein , 2017, EMBO reports.

[8]  H. Lilie,et al.  Common Fibril Structures Imply Systemically Conserved Protein Misfolding Pathways In Vivo. , 2017, Angewandte Chemie.

[9]  D. Agard,et al.  MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy , 2017, Nature Methods.

[10]  Sjors H.W. Scheres,et al.  Helical reconstruction in RELION , 2016, bioRxiv.

[11]  Giampaolo Merlini,et al.  Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines , 2016, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[12]  C. Sigurdson,et al.  Polymorphism of Amyloid Fibrils In Vivo. , 2016, Angewandte Chemie.

[13]  Charles D. Schwieters,et al.  Solid-State NMR Structure of a Pathogenic Fibril of Full-Length Human α-Synuclein , 2016, Nature Structural &Molecular Biology.

[14]  Kai Zhang,et al.  Gctf: Real-time CTF determination and correction , 2015, bioRxiv.

[15]  Nathaniel Echols,et al.  EMRinger: Side-chain-directed model and map validation for 3D Electron Cryomicroscopy , 2015, Nature Methods.

[16]  M. Fändrich,et al.  AA Amyloidosis : Pathogenesis and Targeted Therapy Gunilla , 2014 .

[17]  L. Hooper,et al.  Serum amyloid A is a retinol binding protein that transports retinol during bacterial infection , 2014, eLife.

[18]  Yifan Cheng,et al.  Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis , 2014, Proceedings of the National Academy of Sciences.

[19]  P. Disterer,et al.  Pathogenetic mechanisms of amyloid A amyloidosis , 2013, Proceedings of the National Academy of Sciences.

[20]  G. Merlini,et al.  AA amyloidosis: basic knowledge, unmet needs and future treatments. , 2012, Swiss medical weekly.

[21]  Mathias Jucker,et al.  The Amyloid State of Proteins in Human Diseases , 2012, Cell.

[22]  M. Staufenbiel,et al.  Soluble Aβ Seeds Are Potent Inducers of Cerebral β-Amyloid Deposition , 2011, The Journal of Neuroscience.

[23]  H. Jono,et al.  Transmission of circulating cell-free AA amyloid oligomers in exosomes vectors via a prion-like mechanism. , 2010, Biochemical and biophysical research communications.

[24]  Ulrich Baxa,et al.  β arcades: recurring motifs in naturally occurring and disease‐related amyloid fibrils , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[26]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[27]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[28]  E. Elimova,et al.  Heparan sulfate promotes the aggregation of HDL‐associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  P. Westermark,et al.  Serum amyloid A and protein AA: Molecular mechanisms of a transmissible amyloidosis , 2009, FEBS letters.

[30]  F. Kametani,et al.  Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease , 2008, Proceedings of the National Academy of Sciences.

[31]  S. Arold,et al.  Molecular basis for the lack of enantioselectivity of human 3-phosphoglycerate kinase , 2008, Nucleic acids research.

[32]  B. Penke,et al.  Stepwise dynamics of epitaxially growing single amyloid fibrils , 2008, Proceedings of the National Academy of Sciences.

[33]  Alasdair C. Steven,et al.  Standard Conformations of -Arches in -Solenoid Proteins , 2006 .

[34]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[35]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[36]  Dmitrij Frishman,et al.  STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins , 2004, Nucleic Acids Res..

[37]  Sofia Nyström,et al.  Transmissibility of systemic amyloidosis by a prion-like mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Sipe Revised nomenclature for serum amyloid A (SAA). Nomenclature Committee of the International Society of Amyloidosis. Part 2. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[39]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[40]  J. Sipe,et al.  Polymorphism of acute-phase serum amyloid A isoforms and amyloid resistance in wild-type Mus musculus czech. , 1996, Clinical immunology and immunopathology.

[41]  J R Kremer,et al.  Computer visualization of three-dimensional image data using IMOD. , 1996, Journal of structural biology.

[42]  L. Lovat,et al.  Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Kay,et al.  Structural prerequisites for serum amyloid A fibril formation. , 1993, The Journal of biological chemistry.

[44]  J. Sipe,et al.  Mouse serum amyloid A protein. Complete amino acid sequence and mRNA analysis of a new isoform. , 1992, The Biochemical journal.

[45]  P. Westermark,et al.  The N-terminal segment of protein AA determines its fibrillogenic property. , 1992, Biochemical and biophysical research communications.

[46]  C. Kay,et al.  Circular-dichroism studies on two murine serum amyloid A proteins. , 1988, The Biochemical journal.

[47]  A. Cohen,et al.  The induction of accelerated murine amyloid with human splenic extract , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.

[48]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[49]  W. Ebeling,et al.  Proteinase K from Tritirachium album Limber. , 1974, European journal of biochemistry.

[50]  M. Pras,et al.  PHYSICAL, CHEMICAL, AND ULTRASTRUCTURAL STUDIES OF WATER-SOLUBLE HUMAN AMYLOID FIBRILS : COMPARATIVE ANALYSES OF NINE AMYLOID PREPARATIONS , 1969 .

[51]  G. Glenner,et al.  X-RAY DIFFRACTION STUDIES ON AMYLOID FILAMENTS , 1968, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[52]  H. Puchtler,et al.  ON THE BINDING OF CONGO RED BY AMYLOID , 1962 .

[53]  B. Hazenberg Amyloidosis , 1933, The Indian medical gazette.